David Pincus is a Research Fellow of Microbial Identification in R&D Microbiology at bioMérieux’s St. Louis facility. He has a B.S. in microbiology and public health from Michigan State University and an M.S. in microbiology from Long Island University. He has 41 years of microbiology experience with specific focus in identification product research and development. Dave has 38 publications in peer-reviewed scientific journals including six book chapters. His specialty is yeast identification and taxonomy; he is an Editor for Medical Mycology and serves on the Editorial Board of the Journal of Clinical Microbiology. Dave is a Specialist Microbiologist with the National Registry of Certified Microbiologists (NRCM) and the American Society for Clinical Pathology (ASCP). He has served on Subcommittees and Document Development Committees for the Clinical Laboratory Standards Institute (CLSI) on guidelines M50 (Quality Control for Commercial Microbial Identification Systems), M52 (User Verification/Validation of Microbial Identification and Antimicrobial Susceptibility Testing Systems), and most recently on M58 (Identification of Cultured Microorganisms Using MALDI-TOF), and he is also a member of the CLSI Expert Panel on Microbiology.